Background-Substantial infective endocarditis (IE)-related morbidity and mortality may occur even after successful treatment. However, no previous study has explored long-term hard end points (ie, stroke, myocardial infarction, heart failure, cardiovascular death) in addition to all-cause mortality in IE survivors.
I nfective endocarditis (IE) is an uncommon, but not rare, disease with an estimated incidence of 30 to 100 cases per 1 million patient-years. [1] [2] [3] [4] Despite marked improvements in antibiotic therapy and surgical techniques, more than one third of affected patients die within the first year after hospitalization for IE. 1, 5, 6 IE is characterized by an intense inflammatory response that causes valvular endothelial damage after repeated insults by circulating bacteria. 7 Predisposing conditions may increase the rate of embolic events, which are associated with poor subsequent prognosis. 5, 8 
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European guidelines recommend the active surveillance of signs and symptoms of recurrent IE for 12 months after treatment completion. 9 Short-and long-term mortality risks in IE survivors remain controversial. Some studies have found that mortality is highest in the first year and decreases thereafter (although remaining higher than in the general population) in IE survivors. 10, 11 The direct consequence of IE and underlying conditions may explain this increased short-term mortality. In addition, a recent nationwide population-based study of patients with IE in Sweden found that the increased risk of long-term mortality persists for up to 5 years. 12 Although the long-term mortality of patients with IE has been studied previously, hard end points other than mortality have not been considered by exploring the risk of major adverse cardiac events (MACEs), including stroke, myocardial infarction, heart failure, cardiovascular death, and all-cause death, in these patients.
To reduce the effects of potential confounders stemming from inadequate control for comorbidities and underpowered sample sizes, we used Taiwan's National Health Insurance (NHI) Research Database (NHIRD) to conduct a propensity score-matching study. Our goal was to evaluate long-term adverse cardiac outcomes and mortality in a large, representative group of patients with IE compared with a matched cohort using this nationwide database.
Methods

Data Source
Data were extracted from the NHIRD, which contains anonymized secondary data released for research purposes. Taiwan's NHI program, launched in 1995, currently covers 99% of the population of 23 million people. 13 The database comprises all registry and claims data from the NHI system, ranging from demographic data to detailed orders for ambulatory and inpatient care. Taiwan's NHI Bureau is responsible for auditing medical payments by comprehensive review of medical records, examination reports, and results of imaging studies. If physicians fail to meet the standards for clinical practice, Taiwan's NHI reserves the right to reject payment and can impose huge financial penalties. Disease diagnoses are coded according to the International Classification of Disease, Ninth Revision, Clinical Modification (ICD-9-CM). The study was exempt from full review by the Institutional Review Board of Taipei City Hospital (TCHIRB-1030603-W) because the data set comprised deidentified secondary data.
Study Design
This nationwide population-based, observational, retrospective cohort study was conducted to determine the association between IE and subsequent MACEs. Two cohorts were enrolled in the study: the IE cohort and a matched cohort without IE. The IE cohort, extracted from the entire original NHIRD, consisted of patients with a first-time discharge diagnosis of IE (ICD-9-CM code 421.0, 421.1, and 421.9) between January 2000 and December 2009 who received antibiotic treatment during hospitalization. These codes may be a reliable substitute for chart-based IE diagnosis on the basis of the revised Duke criteria. 14, 15 The result of validation analysis of coded IE diagnosis in Taiwan's NHIRD also had good agreement with that of clinical definite or possible IE in a tertiary center in Taiwan. 16 Patients with the following characteristics were excluded: age <20 years, history of IE, and mortality during hospitalization for IE. The index date was defined as the first day of discharge from IE. The control cohort was extracted from the Longitudinal Health Insurance Database, a subset of the original NHIRD, which contains data from a random sample of 1 million NHI beneficiaries. The exclusion criteria for the IE cohort were also applied to the control cohort. Index dates for subjects in the control cohort were randomly assigned and corresponded to those of patients in the IE cohort.
We used 1:1 propensity score matching and calculated propensity scores for the likelihood of hospitalization for IE using baseline covariates and multivariate logistic regression analysis ( Table I in the online-only Data Supplement). We matched 1 control patient with each patient in the IE cohort with a similar propensity score based on nearest-neighbor matching without replacement using calipers of a width equal to 0.1 SD of the logit of the propensity score.
Outcomes
The following outcomes were of primary interest: hospitalization and principal diagnosis of ischemic stroke (ICD-9-CM code 433.x, 434.x, or 436) and hemorrhagic stroke (ICD-9-CM code 431 or 432), hospitalization and principal diagnosis of myocardial infarction (ICD-9-CM code 410.x), readmission with a principal diagnosis of heart failure (ICD-9-CM code 428.x), and hospitalization or emergency department visit with the principal diagnosis of sudden cardiac death (ICD-9-CM code 427.5, 798.1, or 798.2) and ventricular arrhythmia (including ventricular tachycardia [ICD-9-CM code 427.1] and ventricular fibrillation and flutter [ICD-9-CM code 427. 4, 427.41, or 427 .42]). The secondary outcomes were repeat IE and all-cause death. Repeat IE is defined as any repeat episode of readmission for IE after >1 day after discharge from initial IE episode. 17 Admissions for patients readmitted <1 day after discharge in the same or different hospitals were regarded as the same episode admission. All subjects were followed up until death, loss to follow-up, or December 31, 2010.
Baseline Characteristics
Baseline demographic characteristics examined were age, sex, monthly income (NT$ [New Taiwan dollar] <19 100, NT$19 100−$41 999, and ≥NT$42 000), urbanization, and Charlson Comorbidity Index score. Urbanization levels in Taiwan are divided into 4 strata according to the Taiwan National Health Research Institute. Level 1 designates the most urbanized areas, and level 4 designates the least urbanized areas. The Charlson Comorbidity Index score is used to determine overall systemic health. Each increase in score indicates a stepwise increase in cumulative mortality. 18 Other systemic diseases and risk factors for cardiovascular disease not included in the Charlson Comorbidity Index were also examined; these included coronary artery disease, dyslipidemia, end-stage renal disease, atrial fibrillation, preexisting valvular heart disease, and drug abuse (database codes in Table II in the online-only Data Supplement). Data on concomitant use of medications at discharge after IE associated with cardiovascular events, including aspirin, clopidogrel, ticlopidine, statin, and warfarin, were also extracted.
Statistical Analysis
Descriptive statistics were used to characterize the baseline characteristics of the study cohorts. Baseline characteristics of the 2 groups were compared by use of the Pearson χ 2 test for categorical variables and the independent t test for parametric continuous variables. Propensity scores of the likelihood of IE were determined by multivariate logistic regression analysis, conditional on baseline covariates ( Table I in the online-only Data Supplement). The incidence rates of MACEs in the 2 groups were calculated from Poisson distribution. The cumulative incidence or risk of serious cardiovascular events was estimated by use of the Kaplan-Meier method, and differences between cohorts were evaluated with the log-rank test. Cox regression models with a conditional approach using stratification were used to calculate adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) for the risk of MACEs in each group. 19 We used a bootstrap approach with the inclusion of different criteria for sensitivity analysis to validate the findings of Cox regression models.
Correspondence among bootstrap HRs was tested in 1000 replications. The likelihood ratio test was used to examine the interaction between the occurrence of serious cardiovascular events subsequent to IE and the following variables: age, sex, Charlson Comorbidity Index score, hypertension, cerebrovascular disease, myocardial infarction, diabetes mellitus, coronary artery disease, end-stage renal disease, valvular heart disease, valvular replacement, shock, and year of index date. Subgroup analyses were also performed accordingly. Finally, univariate and multivariate Cox regression models using backward elimination were used to identify predictors of MACEs and repeat IE among IE survivors. Risk factors with a value of P<0.1 were entered into the multivariate analysis.
The 
Results
Characteristics of the Study Population
Between January 2000 and December 2009, a total of 14 792 episodes of hospitalization for IE were identified. The annual detailed descriptive data are shown in Table III and Figure  I in the online-only Data Supplement. Among those, 10 116 patients hospitalized for a first episode of IE between January 2000 and December 2009 who met the inclusion criteria were identified with a mean follow-up period of 4.1 years (SD, 3.1 years). After propensity score matching, we enrolled 8494 patients with IE and 8494 matched cohort in the study. The mean age of the IE cohort was 54.7 years (SD, 18.2 years). The majority of these patients were male (65.7%) and had Charlson Comorbidity Index scores ≥3 (55.7%). Detailed characteristics of both cohorts are provided in Table 1 . Table 2 ). The cumulative incidence of MACEs in patients with IE and the matched cohort is illustrated in the Figure. In the subgroup analyses shown in Tables IV through VI in the online-only Data Supplement, the results are almost consistent with respect to the higher risk of MACEs in the IE cohort compared with the matched cohort.
Long-Term Risk of MACEs
Risk Factors for MACEs and Repeat IE Among IE Survivors
Among a total of 10 116 IE survivors, repeat IE was observed in 1180 patients (11.7%); 56.5% of those (n=667) occurred within first year after an initial episode of IE. The median interval between the initial and repeat episodes of IE was 250 days (quartile 1-3, 81-797 days). In multivariate analysis, male sex (HR, 1.30; 95% CI, 1.14-1.48), drug abuse (HR, 1.50; 95% CI, 1.26-1.79), mechanical valve (HR, 2.11; 95% CI, 1.70-2.62), and bioprosthetic valve replacement (HR, 2.60; 95% CI, 2.16-3.13) were found to be significant risk factors for repeat IE. Repeat IE itself also increased the subsequent risk of hemorrhagic stroke and myocardial infarction but not of ischemic stroke. Other risk factors for MACEs and repeat IE are listed in Table 3 and in Tables VII through X in the online-only Data Supplement.
Sensitivity Analysis for Risk of Serious Cardiovascular Events After IE
As shown in Table 4 , we performed bootstrap sensitivity analyses excluding patients who were followed up for <1 and 2 years after discharge from hospitalization for IE. The associations between IE and stroke, heart failure, and all-cause death remained consistent. Of note, however, the risk of myocardial infarction was not significantly increased in patients with follow-up period of >1 year. The risk of sudden death or ventricular arrhythmia was not increased at >2 years.
Discussion
To the best of our knowledge, this propensity score-matched, nationwide, population-based study is the first to demonstrate that IE survivors had higher rates of MACEs. In addition, we also found that IE survivors had a substantially increased risk of all-cause mortality. Previous population-based studies have found that most deaths resulting from IE occurred within 1 year after hospital discharge. 12, 20, 21 Despite advances in medical and surgical techniques, the treatment of IE remains challenging, with a 5-year mortality rate of ≈40%. 21 One potential explanation was that over their lifetimes IE survivors still carried a risk of 6.3% to 15.6% for a repeat episode in other studies [22] [23] [24] and a similar risk of 11.7% in the present study. In contrast, a retrospective Dutch study 25 showed that the 10-year survival rate of patients who had received surgical treatment for IE was comparable to that of the general population. However, these results may have been affected by the small sample (n=138) and exclusion of subjects deemed unsuitable for the protocol. 26 To resolve this important issue, a large unselected IE cohort was examined in the present study, with propensity score-matched analysis conducted to reduce selection bias. We found that long-term mortality remained greater in 7 Approximately 40% to 50% of IE-related embolic events affect the central nervous system. 27, 28 Moderate to severe stroke has been independently associated with a worse prognosis in patients with IE. 8 Although adequate antibiotic treatment significantly reduces the occurrence of IE-related embolic events, 29 the by guest on April 28, 2017 http://circ.ahajournals.org/ Downloaded from rate of ischemic stroke remains 12.9% to 14% after successful treatment. 8, 27 Most such events occur within the first week, and the rate decreases thereafter. However, the long-term risk of new ischemic stroke events in IE survivors had not been explored before the present study. We found that this risk was 1.6 times higher in IE survivors than in the matched cohort. This result may be explained by the difficulty of completely eradicating microvegetation or a subsequent thrombogenic tendency induced by endocardial damage in IE survivors undergoing prolonged treatment. Although hemorrhagic stroke may occur in only 4% to 7% of patients with IE during the acute stage, 8, 30 many previous studies found that asymptomatic cerebral microbleeds occurred frequently in patients with IE and probably were associated with future events of hemorrhagic stroke. [31] [32] [33] [34] This finding was also confirmed in the present study, which showed that patients with IE had a 2.37-times higher risk of developing long-term hemorrhagic stroke than the matched cohort. Thus, long-term surveillance for neurological complications in IE survivors is essential.
At autopsy, emboli have been found in the epicardial branches of coronary arteries in most patients with IE. 35 However, clinically recognized myocardial infarction is uncommon in patients with IE, and most were reported in case reports or series. [36] [37] [38] The event rate of myocardial infarction in a small-scale study of 481 patients with IE in Spain 39 was similar to that obtained in our study (2.9% versus 2.2%). That study found that most episodes of myocardial infarction (12 of 14 cases) occurred during the first 2 weeks after IE diagnosis. Our findings also support the notion that myocardial infarction is an early complication of IE, probably attributable to direct compression of the coronary arteries by periannular abscess or pseudoaneurysm and coronary embolism. 39 After 1 year of follow-up, no significantly increased risk of myocardial infarction in IE survivors was noted in our study.
This study has several strengths. First, it involved an unselected nationwide population with the most extensive sample of patients with IE available, minimizing the possibility of referral bias. Second, the IE cohort comprised 8494 patients during the 10-year study period, providing adequate statistical power for the analysis of uncommon IE-related long-term MACE outcomes, including stroke, myocardial infarction, heart failure, and sudden death or ventricular arrhythmia. Additionally, we compared study subjects with propensity score-matched control subjects, instead of conducting age-and sex-adjusted analyses in comparison with a general population.
Some limitations of our study should be noted. First, the misclassification of IE is possible, but potential misclassification likely occurred at the same rate in patients with IE and the matched cohort, so this bias likely did not affect the results of the present study. Nevertheless, to overcome the inherent limitations of observational studies based on administrative claims databases, we conducted a propensity score-matched analysis, allowing us to reduce the effects of confounding when using observational data. 40 Second, claims data did not include individual factors such as history of smoking or alcohol use and body mass index. However, both IE and comparator cohorts were so large that the uncollected variables were very likely to have been distributed in a nondifferential pattern, as were the measured variables with approximate propensity to IE. Additionally, data on the type of organisms in patients with IE were not completely recorded in Taiwan's NHIRD because ICD-9-CM codes can be difficult to translate into a microbiological classification. However, our study found that the risk for long-term MACEs did not differ significantly between IE patients with and without diagnosis codes of organism type (data shown in Table XI in the online-only Data Supplement).
European guidelines recommend the careful monitoring of patients with IE for 1 year after discharge because of the high risk of IE recurrence. 9 The results of the present study highlight the substantially increased risk of MACEs in IE survivors. Thus, long-term (>1 year) surveillance of MACEs should also be considered, beyond the period of the greatest risk of IE recurrence. 
SUPPLEMENTAL MATERIAL
